@inbook{1208767089,
author={Vanessa Giuliano and Sze Wah Samuel Chan},
title={Subcutaneous amivantamab with lazertinib is non-inferior to intravenous administration, with fewer adverse reactions},
booktitle={2 Minute Medicine},
publisher={McGraw Hill},
address={New York, NY},
year={2015},
url={accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=649041}
}